SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
NPHC

Nutra Pharma Corp (NPHC)

United States · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - Specialty & Generic
$0.00+$0.00 (+0.00%)
 
Market cap
$1.43M
Insider Score
Market Cap$1.43M+100.0%
Revenue (ttm)$258.91K
Net Income-$5.42M
EPS$0.00
Shares Out7.16B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume237,000
Open$0.00
Previous Close$0.00
Day's Range$0.00 - $0.00
52-Week Range$0.00 - $0.01
Beta65.25
Analystsnone
Price Targetn/a
Earnings Daten/a
No price history available.

About NPHC

Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases in the United States. The company offers Nyloxin/Nyloxin Extra Strength, an over-the-counter (OTC) pain reliever; Pet Pain-Away, a homeopathic, non–narcotic, non–addictive, over–the–counter pain reliever to treat moderate to severe chronic pain in companion animals; Equine Pain-Away, an OTC topical pain reliever to relieve pain in horses; and Luxury Feet, an OTC pain reliever for foot pain from high heels and stilettos. It is also involved in developing RPI-78M to treat neurological and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases comprising human immunodeficiency virus/AIDS and herpes, and general anti -viral applications; RPI-78 for pain and arthritis; and RPI-70 for pain. The company was incorporated in 2000 and is based in Boca Raton, Florida.

Address
6400 Park of Commerce Blvd, Boca Raton, FL, 33487, United States
Market Cap
1 million
Employees
6
Industrial Classification
Drug Manufacturers - Specialty & Generic
1 Day
+0.00%
5 Days
+0.00%
1 Month
+100.00%
6 Months
+100.00%
1 Year
+100.00%

$NPHC stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in NPHC holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by NPHC's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

NPHC Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New NPHC patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to NPHC from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from NPHC’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.